Top Companies in Prefilled Syringes Market

The global prefilled syringes market is projected to reach USD 13.14 billion by 2030 from USD 7.10 billion in 2024, at a CAGR of 10.8% during the forecast period. Market growth is largely driven by the increasing prevalence of chronic diseases, the rise in demand for self-administration, and the advantages of prefilled syringes such as reduced risk of contamination and dosing errors. However, the presence of alternative drug delivery systems and stringent regulatory requirements limit the market growth of prefilled syringes.

Prefilled syringes are syringes that are usually prefilled with medication doses. They are an alternative between a vial and an ampoule that offers convenience for biologics, vaccines, and anticoagulants. The growing demand for homecare, increasing prevalence of chronic diseases, and poor patient compliances are some of the factors that are fueling growth of the prefilled syringes market.

To know about the assumptions considered for the study download the pdf brochure

Glass prefilled syringes are indeed preferred because of their superior chemical resistance, stability, and compatibility with a large number of drugs, especially biologics. Glass prefilled syringes are most widely used in cases where long-term storage of the drug is necessary because they prevent all kinds of interactions between the drug formulation and the container. However, owing to concerns of breakability, interaction with silicone oil, etc., there is continuous active research to consider various alternatives in coatings and designs, but still glass prefilled syringes lead the market, especially in applications where maintaining drug purity is of great concern.

Furthermore, the expansion of the prefilled syringe market owes to the growing demand for self-administration of medications. Patients with long-term conditions such as diabetes and some autoimmune diseases benefit from the convenience and accuracy of glass syringes for injections at home using auto-injector technology. The combination of technology from syringes and auto-injectors has improved patient compliance by overcoming complicated cases of injections, and patient discomfort. This shift towards patient-driven care will increase the demand for glass syringes development, thereby fueling market growth for prefilled syringes.

The prominent players in the prefilled syringes market are BD (US), Gerresheimer AG (Germany), SCHOTT (Germany), and West Pharmaceutical Services, Inc. (US), AptarGroup Inc. (US), Nipro (Japan), Baxter (US), Owen Mumford Ltd. (UK), Weigao Meidcal international Co., Ltd. (China), Credence MedSystems, Inc.(US), Novartis AG (Switzerland), Stevanato Group (Italy), Polymedicure (India), Amsino International, Inc. (US), Sharps Technology, Inc.(US), Fresenius Kabi (US), DBM S.R.L. (Italy), Taisei Kako Co.,Ltd (Japan), Shandong Province Medicinal Glass Co., Ltd.(China), SHIN YAN SHENO PRECISION INDUSTRIAL CO., LTD (Japan), J.O. PHARMA CO., LTD. (Japan), BMIKOREA (Korea), B. Braun SE ( Germany), and Al Shifa Medical Products Co. (Saudi Arabia). These players have adopted various growth strategies such as product launches, acquisition, collabration, agreements, and expansion to increase their presence and reach in the prefilled syringes market.

BD (US)

BD is one of the leading medical technology companies, which manufactures and sells medical devices, reagents, and instruments. Its product line comprises syringes and pen needles; intravenous catheters; infusion pumps and disposables; automated medication dispensing and supply management systems; pre-fillable drug delivery systems; respiratory ventilation and diagnostic equipment and consumables; products for the safe collection and transportation of diagnostic specimens; instruments and reagent systems to detect a range of infectious diseases and cancers; and clinical research tools. The company operates through three business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical comprises of Medication Delivery Solutions, Medication Management Solutions and Pharmaceutical Systems. The company operates in more than 190  countries across North America, Latin America, Europe, the Middle East, Africa, and Asia with 70 manufacturing locations and a total of 297  facilities.

Gerresheimer AG (Germany)

Gerresheimer is one of the leaders in medicine packaging, drug delivery devices, and solutions, offering the most extensive product portfolio for pharmaceuticals, healthcare, well-being, and biotechnology. The company's diverse range of products and solutions comprises of pharmaceutical packaging and items designed for the secure and easy administration of medications. Gerresheimer operates through thre business segments namely, Plastics & Devices, Primary Packaging Glass and Advanced Technologies. The company has over 40 manufacturing plants across Europe, North America, South America, and Asia. Some of its notable subsidiaries include Gerresheimer Querétaro S.A. (Mexico), Gerresheimer Glass Inc. (US), and Gerresheimer Plásticos São Paulo Ltda. (Brazil), Kimble Chase (US), Gerresheimer Medical Plastic Systems Dongguan Co. Ltd. (China), and Triveni Polymers Pvt. Ltd. (India).

SCHOTT (Germany)

Schott AG (SCHOTT), a subsidiary of Carl Zeiss Stiftung AG, is a technology group. It develops, manufactures and markets specialty glass materials and glass-ceramics. The company offers a broad portfolio of special glass, specialty materials, components and systems. SCHOTT Group's operations are organized into three different segments i.e. Precision Materials, Optical Industries and Home Appliances. The Pharma business unit in the Precision materials segment offers syringes, vials, ampoules, cartridges. Geographically, the company operates manufacturing sites and sales offices in 33 countries. Its operations are spread across in Europe, Asia, the Middle East and Africa, North America, and South America.

Related Reports:

Prefilled Syringes Market by Type (Conventional, Safety), Material (Glass Prefilled Syringe, Plastic), Design (Single-Chamber Prefilled Syringe, Dual-Chamber), Application (Diabetes, Cancer, and Rheumatoid Arthritis), & Region - Global Forecast to 2030

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com